Literature DB >> 1117128

Histochemical demonstration of mitochondrial dehydrogenases in developing normal and nervous mutant mouse Purkinje cells.

S C Landis.   

Abstract

The mouse mutation nervous (nr), expressed as a recessive, causes a morphologic change in cerebellar Purkinje cell perikaryonal mitochondria during the 2nd postnatal week which is followed by the selective degeneration of most Purkinje cells. In the present study, mitochondrial dehydrogenase activities (succinic acid dehydrogenase, lactic acid dehydrogenase, malic acid dehydrogenase, reduced diphosphopyridine nucleotide diaphorase and succinic semialdehyde dehyrogenase) are found by light microscopy to be similar in the perikarya of normal and nervous Purkinje cells until after mitochondrial rounding has begun to occur, but then staining increases markedly in nervous. Although only a small fraction of mitochondrial functions were examined, those enzymes assayed were present and competent. In a sense, the only mitochondrial abnormalities demonstrated thus far in nervous Purkinje cells are their unusual shape and probable loss of motility.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1117128     DOI: 10.1177/23.2.1117128

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  3 in total

1.  Excessive activation of tissue plasminogen activator makes a mouse nervous.

Authors:  Dan Goldowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-21       Impact factor: 11.205

2.  Purkinje neuron degeneration in nervous (nr) mutant mice is mediated by a metabolic pathway involving excess tissue plasminogen activator.

Authors:  Jianxue Li; Yinghua Ma; Yang D Teng; Kangni Zheng; Timothy K Vartanian; Evan Y Snyder; Richard L Sidman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-08       Impact factor: 11.205

Review 3.  Neuronal nitric oxide synthase expression in cerebellar mutant mice.

Authors:  Louise C Abbott; Sang-Soep Nahm
Journal:  Cerebellum       Date:  2004       Impact factor: 3.648

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.